Do not miss the early registration fee deadline

12 October 2017 
REGISTER NOW
 
image4
 
This year the focus on treatment resistant depression includes the advances in personalised medicine, the increasing data on rapid response with esketamine, the most important clinical predictors of TRD and the exciting data on new genetic pathways which alter response and resistance in depression.
 
image5
 
There are overviews of the therapeutic implications of affective symptoms in schizophrenia and the impact of new findings on the treatment of primary and secondary negative symptoms of schizophrenia. 
 
image4
 
An important component of the meeting will be updates on the management of bipolar disorder with reviews of lithium and long-acting injectable antipsychotics and how to manage bipolar disorder with comorbid ADHD. 
 
 
VIEW THE SCIENTIFIC PROGRAMME
 
divider-shadow
divider-shadow
set6-image6
 
set6-image7
 
DEADLINES
divider-shadow
set4-icon-computer
 
06 NOVEMBER 2017
DEADLINE FOR ABSTRACT SUBMISSION
set4-icon-calenda
 
11 NOVEMBER 2017
NOTIFICATION FOR ABSTRACT POSTER SUBMISSION
set4-icon-graph
 
16 DECEMBER 2017

STROLLING POSTER SESSION 08:10 – 09:10

POSTER AWARDS

12:00 – 12:15

divider-shadow
Hoping to welcoming you in Madrid
IFMAD 2017 Scientific and Organizing Committee
divider-shadow
 
image1
POWERED BY
Publi Créations
Address: 74, bd d’Italie - 98000 MONACO
Phone: + 377.97973555
Fax: + 377.97973550
Email: ifmad@publicreations.com